ADT1633-Tefibazumab Biosimilar-(Fibrin-binding surface epitope clumping factor A)-Research Biosimilar Antibody
- +1 609-736-0910
- info@alphalifetech.com
- 90 State Street, STE 700 Office 40, Albany, NY 12207 United States
Product Background
Catalog Number |
ADT1633 |
Product Name |
ADT1633-Tefibazumab Biosimilar-(Fibrin-binding surface epitope clumping factor A)-Research Biosimilar Antibody |
Alternate Names |
anti-mouse clumping factor A antibody, anti-clumping factor A antibody, anti clumping factor A antibody, recombinant clumping factor A, clumping factor A antibody, anti-clumping factor A monoclonal antibody, clumping factor A antibodies |
Alias |
Aurexis |
Clonity |
Monoclonal |
Host |
CHO Cells |
Species |
Human |
Target |
Clumping factor A |
Isotype |
IgG1 Kappa |
Size |
1mg, 5mg |
Research Area |
Immunology |
CAS Number |
521079-87-8 |
Product Description |
Tefibazumab (named Aurexis but not approved) is a humanized monoclonal antibody for the treatment of severe infections with Staphylococcus aureus. Possible indications include the treatment of S. aureus in a phase 2a patients with cystic fibrosis and of methicillin-resistant S. aureus. |
Application |
FC, IP, ELISA, Neut, Functional assay, IF |
Purity |
>95% as determined by SDS-PAGE |
Concentration |
batch dependent |
Buffer |
Supplied in PBS, PH7.5 |
Storage |
Store at -20 °C for 12 months. Store at -80 °C for long term storage. |
Shipping Condition |
Shipped on ice packs. |
Note |
This product is for research use only. |





